Ros1-positive Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Ros1-positive Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors
Expanded access program for Zidesamtinib (NVL-520) in patients with advanced ROS1-positive solid tumors, including ROS1-positive non-small c…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer [Phase 2]
A phase 2 neoadjuvant trial of WX-0593 for resectable ALK-positive or ROS1-positive non-small cell lung cancer is currently recruiting.